Alphamab Oncology

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG0330A1013
HKD
6.95
-0.66 (-8.67%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryAlphamab Oncology VS Pharmaceuticals & Biotechnology
 
1D
-8.67%
-1.78%
1W
-9.27%
1.6%
1M
-2.66%
1.03%
YTD
-29.08%
-4.17%
1Y
-16.27%
0.26%
3Y
-25.67%
26.52%
5Y
-73.82%
-12.29%
10Y
%
13.4%
  • Stock Absolute Returns
  • Hang Seng Hong KongAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-41.6%
0%
-41.6%
6 Months
-31.86%
0%
-31.86%
1 Year
-16.27%
0%
-16.27%
2 Years
200.87%
0%
200.87%
3 Years
-25.67%
0%
-25.67%
4 Years
-2.39%
0%
-2.39%
5 Years
-73.82%
0%
-73.82%

Alphamab Oncology for the last several years.

stock-summaryRisk Adjusted Returns v/s Hang Seng Hong Kong
Risk Adjusted Returns v/s stock-summary